Amgen Gives Update Regarding Drug Trials By: Benzinga via Benzinga March 17, 2015 at 10:38 AM EDT RBC Capital Markets issued a report on Amgen, Inc. (NASDAQ: AMGN) after the company presented at the ACC conference. The firm ... Read More >> Related Stocks: Amgen